| Rola M S Alsawadi, RPH | |
|
2811 Holmans Ln, Jeffersonville, IN 47130-5915 | |
| (812) 288-9287 | |
| Not Available |
| Full Name | Rola M S Alsawadi |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2811 Holmans Ln, Jeffersonville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346991585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | CV2103407 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rola M S Alsawadi, RPH 2811 Holmans Ln, Jeffersonville, IN 47130-5915 Ph: (812) 288-9287 | Rola M S Alsawadi, RPH 2811 Holmans Ln, Jeffersonville, IN 47130-5915 Ph: (812) 288-9287 |
News Archive
Medtronic, Inc. today announced the results of a double-blind, randomized study, ISSUE-3, which found that patients who suffered from fainting due to neurocardiogenic syncope had fewer fainting occurrences when treated with a Medtronic pacemaker.
While carotid endarterectomy (CEA) is performed to prevent stroke, long-term survival is essential to ensure benefit, especially in asymptomatic patients. A new study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery today examined patient factors associated with 5-year survival following CEA in patients with asymptomatic internal carotid artery (ICA) stenosis.
Today's early morning highlights from the major news organizations, including reports about a new "Obamacare" ad in the Arkansas Senate race and a California poll measuring how the state's voters feel about a ballot initiative that would expand the state's ability to regulate health insurance rates.
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2018 argue for brigatinib as a first-line treatment option for advanced ALK-positive non-small cell lung cancer.
Despite a veto threat from the White House, the House on Wednesday voted 349-62 to approve legislation (HR 5613) that would place a one-year moratorium on seven new Medicaid regulations, the AP/Houston Chronicle reports (Abrams, AP/Houston Chronicle, 4/24).
› Verified 9 days ago
Suzanne Ruth Roberts, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5653 Bailey Grant Rd, Jeffersonville, IN 47130 Phone: 502-558-4307 | |
Ryan Lee Tarr, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2811 Holmans Ln, Jeffersonville, IN 47130 Phone: 812-288-6225 | |
Hilary Van Horn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1002 Spring St, Jeffersonville, IN 47130 Phone: 812-292-2256 | |
Mrs. Pamela Kay Leezer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Vissing Park Rd, Jeffersonville, IN 47130 Phone: 812-258-1001 | |
Brandi Corbett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2750 Allison Ln, Jeffersonville, IN 47130 Phone: 812-218-6610 | |
Ms. Lee Ann Mccandless, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2811 Holmans Ln, Jeffersonville, IN 47130 Phone: 812-288-9287 Fax: 812-285-0237 | |
Breeellen Shroyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1050 Patrol Rd, Jeffersonville, IN 47130 Phone: 855-427-4682 |